中山割痔疮的费用是多少-【中山华都肛肠医院】,gUfTOBOs,中山肛门旁长疙瘩,中山大便完后屁股出血,中山痔疮应该怎么办,中山华都肛肠医院地址,中山肚子痛拉肚子带血,中山怎样治疗痣疮

As millions of Americans head to the polls today for the last day of voting, a group of artists has been deployed to help them pass the time.With a strum of her bow, violinist Paula Johannessen is off.“Some poll workers were really excited, too, that they were just happy to hear music,” said Johannessen.But today, her performance is dedicated to the American voter.“I played a lot of Irish music so far, and I'll continue to some jigs reels and waltzes,” she said.It’s called Play for the Vote, a non-partisan effort by artists and performers to bring music to the ballot box.“It's nice to remind people that we are still here, we're still performing, we're still here to share what we have with everybody,” explained Johannessen.Boston-based cellist Mike Block came up with the idea after the contentious first presidential debate.“I was just kind of thinking about what the candidates were saying about, not just who you should vote for, but the stress around the process of voting itself,” said Block.With long lines, health concerns, and the fate of the country hanging in the balance, Block decided musicians could help ease the anxiety.“I think it's also this is going to serve a very important need for audiences, said Block.“Music has this unique power to create shared unifying experiences and we haven't really had that this year.”He recruited 600 musicians to perform classical, folk, bluegrass, jazz, rock and more without a political leaning. They will play in 48 states and the District of Columbia. All of it is for voters stuck in long lines, fulfilling their civic duty.“It's always been a melting pot of music, as well as cultures here, and it's really cool just to be able to communicate with anyone anywhere through music,” said Johannessen.“I think encountering this at a voting location is really going to remind people of the culture and all of the things that bring us together in society,” said Block.It’s a good reminder of what we have in common today, no matter who we vote for. 2016
As states prepare to assist in distributing potential coronavirus vaccines by November 1, Surgeon General Jerome Adams doubted a vaccine would be ready so soon.Speaking to ABC’s Good Morning America, Adams said a Nov. 1 vaccine was “possible, but not probable.”Last week, the federal government asked states to be prepared to begin assisting in distribution of COVID-19 vaccines to the public this fall.The memo signed by CDC head Robert Redfield told governors that the federal government has contracted with the McKesson Corporation to assist in distributing the vaccine to local and state health departments, medical facilities, doctor officers, and other vaccine providers.So why is the government getting states ready for a vaccine on November 1 even if it’s unlikely a vaccine will be approved by then?"It's not contradictory information," Adams told Good Morning America. "We've always said that we're hopeful for a vaccine by the end of this year or the beginning of next year.""We want to make sure states are available to distribute it," he added.While there is urgency for both public health and economic reasons for a vaccine, some experts have expressed concern over the speed of a vaccine and whether the expedited timeline is long enough to demonstrate efficacy. Dr. Anthony Fauci told NBC News on Wednesday that he believes a “safe and effective” vaccine could be ready by the end of the year."I believe that by the time we get to the end of this calendar year, that we will feel comfortable that we do have a safe and effective vaccine," he told NBC News.On Monday, a third vaccine candidate entered “Phase 3” trials in the US. AstraZeneca is testing its COVID-19 vaccine candidate for 30,000 participants. The AstraZeneca vaccine would come in two separate doses, according to the National Institutes of Health.Even though a vaccine could be ready by year’s end, trials will be expected to continue for over a year to monitor for possible side effects.According to the FDA, a typical Phase 3 trial would take one to three years.“NIH is committed to supporting several Phase 3 vaccine trials to increase the odds that one or more will be effective in preventing COVID-19 and put us on the road to recovery from this devastating pandemic,” said NIH Director Francis S. Collins, M.D., Ph.D. “We also know that preventing this disease could require multiple vaccines and we’re investing in those that we believe have the greatest potential for success.”On Friday, President Donald Trump reiterated that a vaccine would be ready soon."We have tremendous, tremendous talent, some tremendous scientists, and they're right there, and I think you're going to hear some very good news,” Trump said. 2714

ATLANTA (AP) — New Orleans Saints safety Malcolm Jenkins is joining CNN as a contributor focusing on racial and social justice. Malcom posted the news on Twitter."Proud to join the @CNN family today as a regular contributor," Malcolm tweeted. "Looking forward to being heard." 284
At least two people were injured when an air duct fell from the ceiling at Kalahari Resort in Sandusky, Ohio, according to the Erie County sheriff's office.According to a 911 caller, a 25-foot section of the duct fell into a pool area.Went to kalahari for a fun day with my daughter and now we have to leave bc of the tubes fell pic.twitter.com/2S3j9M33q5— Phil is to sweet (@Philsmarshmalow) March 12, 2018 415
Authorities will begin distributing an experimental Ebola vaccine in Mbandaka, a major city in the Democratic Republic of Congo, on Monday to try to stop the spread of the deadly virus.Healthcare workers in Mbandaka, the capital of Equateur Province and home to 1.2 million people, will be the first to receive the vaccine, World Health Organization spokesman Tarik Ja?arevi? said.The confirmation of the first case in Mbandaka last week has raised concerns that the virus could spread faster than expected. So far, 26 people have died in the outbreak, according to the WHO.The vaccine, called rVSV-ZEBOV, will likely be distributed to some 8,000 to 10,000 people in its first phase, Peter Salama, deputy director-general of emergency preparedness and response at the WHO, said Friday.It will be given to people who have had contact with people infected with Ebola and contacts of those contacts, Salama said.Ebola is an incredibly contagious virus which causes the sudden onset of symptoms including fever, fatigue and muscle pain within two to 21 days after infection. Patients suffer vomiting, rash and diarrhea, impaired kidney and liver function -- and in some cases internal and external bleeding.An outbreak in 2014 in West Africa killed more than 11,000 people in months. 1287
来源:资阳报